Your browser doesn't support javascript.
Hydroxychloroquine as prophylaxis or treatment for COVID-19: What does the evidence say?
Indian J Public Health ; 64(Supplement): S125-S127, 2020 Jun.
Artículo en Inglés | MEDLINE | ID: covidwho-538987
Hydroxychloroquine (HCQ), an antimalarial has been proposed as possible treatment for coronavirus disease-2019 (COVID-19). India has approved the use of HCQ for prophylaxis of asymptomatic health workers treating suspected or confirmed COVID-19 cases, and asymptomatic household contacts of confirmed patients. The U.S. Food and Drug Administration has issued Emergency Use Authorization for the use of HCQ to treat COVID-19 in adolescents and adults. In this review, we go over the available evidence for and against HCQ's use as prophylaxis or treatment for COVID-19, especially in the Indian context.





Texto completo: Disponible Base de datos: MEDLINE Tipo del documento: Artículo Asunto principal: Neumonía Viral / Infecciones por Coronavirus / Hidroxicloroquina / Antimaláricos Tipo de estudio: Sintesis de evidencia Idioma: Inglés Revista: Indian J Public Health Aspecto clínico: Terapia Año: 2020